MSPM Platform: Technical Overview of Molecule-Structured Protein Matrix for Targeted Cellular Restoration (v1.0)
Volodymyr Naumenko
Founder & CEO, Patented MT Company (Vilnius, Lithuania)
Academician of the Ukrainian Technological Academy
Department of Modern Medical Technologies and Ecology
ORCID: 0009-0000-3965-5205
This document provides a technical overview of the MSPM (Molecule-Structured Protein Matrix) platform, developed by Patented MT.
The technology focuses on the transition of protein architecture from globular configurations to a stable, filamentous matrix. This approach implements a “metabolic bypass” mechanism, designed to facilitate direct amino acid assimilation and reduce energy expenditure associated with enzymatic fermentation.
Technical focus areas include:
- Nitrogen retention and balance: The platform uses the metabolic bypass route to ensure maximum nitrogen retention, serving as the primary marker for assessing protein metabolism and muscle mass preservation.
- Bio-digital integration: The MSPM platform serves as a tool for the cybernetic regulation of metabolic processes.
- Metabolic bypass mechanism: Enables nutrient uptake that minimizes ATP expenditure during the assimilation process.
- Steric and thermodynamic optimization: Replaces spatial shielding with a linear architecture to improve systemic nitrogen fixation and reduce metabolic stress.
- Application framework: Provides a basis for precision nutrition, systemic metabolic control, and support for cellular restoration processes.
This technical note details the biochemical and systems-engineering rationale for the application of filamentous matrices in managing human physiological processes and optimizing nitrogen turnover through bio-digital instrumentation.
Full publication available via DOI: https://doi.org/10.5281/zenodo.21259430